Project Grant 20236703440407
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $129,619 to the University of Colorado-Denver on September 1, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds a five-year research project extending through May 31, 2030, investigating the interactions between gut microbiome composition, intestinal development, and metabolic health outcomes in offspring...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $140,116.00 to the Beckman Research Institute of the City of Hope on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support research on gut-fat crosstalk in metabolic regulation. The research project, which extends through July 31, 2028, investigates the communication mechanisms between the intestine and...
- Federal Grant Award Summary Tufts University School of Medicine received a $838,493 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded April 15, 2026, with completion targeted for February 28, 2031. The award funds the NOURISH (Nutrition Intervention Optimization to Better Utilize Resources and Support Health) Study, which will develop and test...
- Federal Project Grant Award Summary The University of Chicago received a $147,486 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of September 30, 2025, and completion date of September 29, 2028. The research focuses on establishing the role of gut microbiota in regulating interleukin-22 (IL-22) production and its effects on pancreatic...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $229,076 to the University of North Carolina at Chapel Hill under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 15, 2025, with a completion date of March 31, 2030. Under this Project Grant, Dr. Joseph Burclaff, mentored by Dr. Scott Magness in the Department of Biomedical Engineering, will conduct research investigating...
- Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Rutgers The State University of New Jersey $235,500 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) through a Project Grant mechanism. The award, effective September 15, 2025, through September 14, 2027, funds research investigating gut microbial functions that influence Crohn's disease risk in both multiplex (multi-affected family) and...
- This two-year, $120,000 Project Grant from the United States Department of Agriculture National Institute of Food and Agriculture (USDA NIFA) through the Agriculture and Food Research Initiative (AFRI) will fund research into the anti-inflammatory effects of resistant starch from whole grain sorghum in a mouse model. Specifically, the University of Nebraska will use near-isogenic low-resistant starch sorghum mutants and parental varieties to investigate how resistant starch in a whole food...
- Federal Grant Award Summary The University of Illinois received a $163,511 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through May 31, 2030. This award supports research investigating the mechanisms by which fructooligosacharides (FOS), a dietary fiber, mitigates Western diet-induced obesity in mice by reducing hypothalamic...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $183,600 Project Grant to the University of Utah on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This K23 Patient-Oriented Mentored Award provides structured research and career development support through May 31, 2030, to prepare Dr. Amiko Uchida, MD, a gastroenterologist at the University of Utah's Eosinophilic...
- Federal Project Grant Award Summary Yale University received a $802,843 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 13, 2025, with completion targeted for June 30, 2030. The research will investigate the pathogenic mechanisms linking obesity to cardiometabolic complications in pediatric populations, with specific focus on how...
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** THIS RESEARCH PROJECT AIMS TO INVESTIGATE A WHOLE FOOD'S EFFECT ON THE GUT MICROBIOME TO IMPROVE HUMAN HEALTH AND ADVANCE THE NUTRITION FIELD BY DETERMINING THE ROLE OF WHOLE FOOD IN CHRONIC DISEASE. WE AIM TO INVESTIGATE THE ROLE OF THE MICROBIOME IN MEDIATING THE RENAL PROTECTIVE EFFECTS OF WHOLE OATS IN TYPE 2 DIABETES. DIABETES IS THE MOST PREVALENT CAUSE OF END-STAGE RENAL KIDNEY DISEASE IN THE WORLD. OUR RESEARCH GROUP HAS DEMONSTRATED THAT RESISTANT STARCH, A LOW GLYCEMIC INDEX CARBOHYDRATE HIGH IN FERMENTABLE FIBER, ATTENUATED THE PROGRESSION OF DIABETIC NEPHROPATHY. THE POSSIBLE BENEFITS OF RESISTANT STARCH CONSUMPTION FOR THE INHIBITION OF DIABETIC NEPHROPATHY ARE PROMISING, YET REGULAR CONSUMPTION OF THIS FIBER MAY NOT BE SUSTAINABLE DUE TO PALATABILITY ISSUES. WHOLE OATS REPRESENT A FERMENTABLE LOW GLYCEMIC CARBOHYDRATE SOURCE THAT IS MORE PALATABLE AND PRODUCES A FAVORABLE GLYCEMIC RESPONSE IN DIABETICS. THE IMPACT OF OATS ON NEPHROPROTECTION AND WHETHER THE MICROBIOME MEDIATES THIS EFFECT ARE UNCLEAR.TO TACKLE THIS ISSUE, WE PLAN TO COMPLETE TWO PRE-CLINICAL STUDIES, WHERE TYPE 2 DIABETIC RATS WILL CONSUME A DIET HIGH IN WHOLE OATS TO DETERMINE WHETHER THEIR FERMENTATION BY THE GUT MICROBIOME CAN ATTENUATE KIDNEY DISEASE, COMPARED TO A CONTROL GROUP. SERUM, FECES, AND TISSUES WILL BE COLLECTED AFTER AN EIGHT-WEEK FEEDING STUDY, AND RENAL FUNCTION WILL BE ASSESSED TO DETERMINE THE EFFECT OF WHOLE OATS ON DIABETIC NEPHROPATHY. DEPENDING ON OUR RESULTS, WE WILL FOLLOW UP THIS STUDY WITH A FECAL MICROBIOTA TRANSPLANTATION STUDY, WHERE RECIPIENT RATS WILL RECEIVE FECAL MATERIAL FROM DIABETIC DONORS FED WITH WHOLE OATS AND RESISTANT STARCH TO ASSESS IF THE GUT MICROBIOME MEDIATES THE NEPHROPROTECTIVE EFFECTS. WE ALSO PLAN TO DEMONSTRATE THAT THIS DIETARY INTERVENTION IS FEASIBLE FOR TRANSLATIONAL STUDIES, AS WE WILL UTILIZE MODERATE LEVELS OF WHOLE OATS AND RESISTANT STARCH IN THE PROPOSED STUDIES. UNDERSTANDING THE ROLE OF WHOLE FOOD IN IMPROVING THE PROGRESSION OF SUCH PREVALENT DISEASE WILL PROVIDE A NOVEL UNDERSTANDING OF THE NEPHROPROTECTIVE MECHANISMS OF ACTIONS OF DIETARY WHOLE OATS AND RESISTANT STARCH TO THE NUTRITIONAL SCIENCE FIELD.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $156.1k | 5/31/23 |